Involvement of growth hormone as a regulating factor in sex differences of mouse hepatic aldehyde oxidase

Biochemical Pharmacology

Volumn 53, Issue 8, 1997, Pages 1099-1105

  Yoshihara, Shin'ichi ^a   Tatsumi, Kiyoshi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

aldehyde oxidase; growth hormone; hypophysectomy; monosodium aspartate; monosodium glutamate; mouse liver; sex differences; testosterone propionate; xanthine oxidase

Indexed keywords

ALDEHYDE OXIDASE; ASPARTATE SODIUM; ESTRADIOL BENZOATE; GLUTAMATE SODIUM; GROWTH HORMONE; LIVER ENZYME; TESTOSTERONE PROPIONATE;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HORMONAL REGULATION; HYPOPHYSECTOMY; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ALDEHYDE OXIDASE; ALDEHYDE OXIDOREDUCTASES; ANIMALS; ANIMALS, NEWBORN; ASPARTIC ACID; FEMALE; GROWTH HORMONE; HYPOPHYSECTOMY; LIVER; MALE; MICE; SEX FACTORS; SODIUM GLUTAMATE;

EID: 0030909088     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00088-9     Document Type: Article

References (42)

1. Beedham C, Molybdenum hydroxylases as drug-metabolizing enzymes. Drug Metab Rev 16: 119-156, 1985.
2. Yoshihara S and Tatsumi K, Guinea pig liver aldehyde oxidase as a sulfoxide reductase: its purification and characterization. Arch Biochem Biophys 242: 213-224, 1985.
3. Turner NA, Doyle WA, Ventom AM and Bray RC, Properties of rabbit liver aldehyde oxidase and the relationship of the enzyme to xanthine oxidase and dehydrogenase. Eur J Biochem 232: 646-657, 1995.
4. Calzi ML, Raviolo C, Ghibaudi E, Gioia LD, Salmona M, Cazzaniga G, Kurosaki M, Terao M and Garattini E, Purification, cDNA cloning, and tissue distribution of bovine liver aldehyde oxidase. J Biol Chem 270: 31037-31045, 1995.
5. Rajagopalan KV, Xanthine oxidase and aldehyde oxidase. In: Enzymatic Basis of Detoxification (Ed. Jakoby WB), Vol. 1, pp. 295-310. Academic Press, New York, 1980.
6. Krenitsky TA, Neil SM, Elion GB and Hitchings GH, A comparison of the specificities of xanthine oxidase and aldehyde oxidase. Arch Biochem Biophys 150: 585-599, 1972.
7. Guo X, Lerner-Tung M, Chen HX, Chang CN, Zhu JL, Chang CP, Pizzorno G, Lin TP and Cheng YC, 5-Fluoro-2-pyrimidinone, a liver aldehyde oxidase-activated prodrug of 5-fluorouracil. Biochem Pharmacol 49: 1111-1116, 1995.
8. Chang CN, Doong SL and Cheng YC, Conversion of 5-iodo-2-pyrimidinone-2′-deoxyribose to 5-iodo-deoxyuridine by aldehyde oxidase. Implication in hepatotropic drug design. Biochem Pharmacol 43: 2269-2273, 1992.
9. Clarke SE, Harrell AW and Chenery RJ, Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver. Drug Metab Dispos 23: 251-254, 1995.
10. Miranda PD and Good SS, Species differences in the metabolism and disposition of antiviral nucleoside analogues. 1. Acyclovir. Antiviral Chem Chemother 18: 1-8, 1992.
11. Robertson IGC and Bland TJ, Inhibition by SKF-525A of the aldehyde oxidase-mediated metabolism of the experimental antitumour agent acridine carboxamide. Biochem Pharmacol 45: 2159-2162, 1993.
12. Yoshihara S and Tatsumi K, Metabolism of diphenyl sulfoxide in perfused guinea pig liver: Involvement of aldehyde oxidase as a sulfoxide reductase. Drug Metab Dispos 18: 876-881, 1990.
13. Lee SC and Renwick AG, Sulphoxide reduction by rat and rabbit tissues in vitro. Biochem Pharmacol 49: 1557-1565, 1995.
14. Kitamura S and Tatsumi K, Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide. Biochem Biophys Res Commun 120: 602-606, 1984.
15. Sugihara K, Kitamura S and Tatsumi K, Involvement of liver aldehyde oxidase in conversion of N-hydroxyurethane to urethane. J Pharmacobiodyn 6: 677-683, 1983.
16. Kitamura S, Sugihara K and Tatsumi K, Reductase activity of aldehyde oxidase toward the carcinogen N-hydroxy-2-acetylaminofluorene and the related hydroxamic acids. Biochem Mol Biol Int 34: 1197-1203, 1994.
17. Kitamura S and Tatsumi K, Azoreductase activity of liver aldehyde oxidase. Chem Pharm Bull (Tokyo) 31: 3334-3337, 1983.
18. Stoddart AM and Levine WG, Azoreductase activity by purified rabbit liver aldehyde oxidase. Biochem Pharmacol 43: 2227-2235, 1992.
19. Kitamura S, Narai N and Tatsumi K, Rabbit liver enzymes responsible for reduction of nitropolycyclic aromatic hydrocarbons. Chem Pharm Bull (Tokyo) 31: 776-779, 1983.
20. Bauer SL and Howard PC, Kinetics and cofactor requirements for the nitroreductive metabolism of 1-nitropyrene and 3-nitrofluoranthene by rabbit liver aldehyde oxidase. Carcinogenesis 12: 1545-1549, 1991.
21. Hirao Y, Kitamura S and Tatsumi K, Epoxide reductase activity of mammalian liver cytosols and aldehyde oxidase. Carcinogenesis 15: 739-743, 1994.
22. Rodrigues AD, Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro. Biochem Pharmacol 48: 197-200, 1994.
23. Krenitsky TA, Tuttle JV, Cattau EL Jr and Wang P, A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase. Comp Biochem Physiol 49B: 687-703, 1974.
24. Watson JG, Higgins TJ, Collins PB and Chaykin S, The mouse liver aldehyde oxidase locus (Aox). Biochem Genet 6: 195-204, 1972.
25. Sugihara K, Kitamura S and Tatsumi K, Strain differences of liver aldehyde oxidase activity in rats. Biochem Mol Biol Int 37: 861-869, 1995.
26. 1-methylnicotinamide oxidase activity in mice. J Biol Chem 242: 1265-1270, 1967.
27. Gluecksohn-Waelsch S, Greengard P, Quinn GP and Teicher LS, Genetic variations of an oxidase in mammals. J Biol Chem 242: 1271-1273, 1967.
28. Tannenbaum GS, Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin. Endocrinology 108: 76-82, 1981.
29. Wehrenberg WB, Janowski BA, Piering AW, Culler F and Jones KL, Glucocorticoids: Potent inhibitors and stimulators of growth hormone secretion. Endocrinology 126: 3200-3203, 1990.
30. Millard WJ, Martin JB Jr, Audet J, Sagar SM and Martin JB, Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 110: 540-550, 1982.
31. Pampori NA and Shapiro BH, Effects of neonatally administered monosodium glutamate on the sexually dimorphic profiles of circulating growth hormone regulating murine hepatic monooxygenases. Biochem Pharmacol 47: 1221-1229, 1994.
32. Yamazoe Y, Shimada M, Murayama N, Nagata K and Kato R, Hormonal regulation of hepatic cytochrome P-450. In: Xenobiotic Metabolism and Disposition (Eds. Kato R, Estabrook RW and Cayen MN), pp. 37-44. Taylor & Francis, London, 1988.
33. Yamazoe Y, Shimada M, Murayama N, Yamauchi K and Kato R, Alteration of hepatic drug metabolizing activities and contents of cytochrome P-450 isozymes by neonatal monosodium glutamate treatment. Biochem Pharmacol 37: 1687-1691, 1988.
34. Pampori NA, Agrawal AK, Waxman DJ and Shapiro BH, Differential effects of neonatally administered glutamate on the ultradian pattern of circulating growth hormone regulating expression of sex-dependent forms of cytochrome P450. Biochem Pharmacol 41: 1299-1309, 1991.
35. MacLeod JN and Shapiro BH, Growth hormone regulation of hepatic drug-metabolizing enzymes in the mouse. Biochem Pharmacol 38: 1673-1677, 1989.
36. Stirpe F and Corte ED, The regulation of rat liver xanthine oxidase: Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J Biol Chem 244: 3855-3863, 1969.
37. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
38. Agrawal AK, Pampori NA and Shapiro BH, Sex-and dose-dependent effects of neonatally administered aspartate on the ultradian patterns of circulating growth hormone regulating hexobarbital metabolism and action. Toxicol Appl Pharmacol 108: 96-106, 1991.
39. MacLeod JN, Pampori NA and Shapiro BH, Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J Endocrinol 131: 395-399, 1991.
40. Shapiro BH, Pampori NA, Ram PA and Waxman DJ, Irreversible suppression of growth hormone-dependent cytochrome P450 2C11 in adult rats neonatally treated with monosodium glutamate. J Pharmacol Exp Ther 265: 979-984, 1993.
41. Yoshihara S and Tatsumi K, Purification and characterization of hepatic aldehyde oxidase in male and female mice. Arch Biochem Biophys, in press.
42. Jansson JO, Ekberg S, Isaksson O, Mode A and Gustafsson JA, Imprinting of growth hormone secretion, body growth, and hepatic steroid metabolism by neonatal testosterone. Endocrinology 117: 1881-1889, 1985.